As of November 6, 2026, Trinity Biotech plc is a publicly traded company (Nasdaq: TRIB). The largest holder reporting an active stake on Schedule 13D is MiCo IVD Holdings, LLC, at 17%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Novus Diagnostics Ltd. (5.99%) (Schedule 13D/A, December 10, 2025).
Is this your company?
About to sign with, pay or invest in Trinity Biotech plc? See the free Snapshot first.
Free to see. No signup.
Is Trinity Biotech plc a real, registered company?
- Trinity Biotech plc files with the SEC under CIK 888721 (its SEC filings).
- Its shares are listed under the ticker TRIB on Nasdaq (SEC company record).
- Incorporated in L2, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Trinity Biotech plc in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Perceptive Advisors (filed 2026-05-04).
Who are Trinity Biotech plc's owners and officers?
Trinity Biotech plc: industry In Vitro & In Vivo Diagnostic Substances (F-1/A, 2026-08-21).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-05-04 | Perceptive Advisors LLC | 9.9% |
| Schedule 13G, 2026-03-06 | Novus Diagnostics LTD. | 5.99% |
| Schedule 13D/A, 2026-01-26 | Perceptive Advisors LLC | 9.9% |
| Schedule 13D/A, 2025-12-23 | Perceptive Advisors LLC | 9.9% |
| Schedule 13D/A, 2025-12-15 | Dayli Partners, Inc. | 0% |
| Schedule 13D/A, 2025-12-10 | Mico Ivd Holdings, LLC | 17% |
| Schedule 13D/A, 2025-12-04 | Mico Ivd Holdings, LLC | 17% |
| Schedule 13D/A, 2025-10-24 | Perceptive Advisors LLC | 22.5% |
Questions about who owns Trinity Biotech plc
Who owns Trinity Biotech plc?
On this page, 3 holders' latest ownership filings report 5% or more of Trinity Biotech plc: Mico Ivd Holdings, LLC (17%, Schedule 13D/A, filed 2025-12-10), Perceptive Advisors LLC (9.9%, Schedule 13D/A, filed 2026-05-04) and Novus Diagnostics LTD. (5.99%, Schedule 13G, filed 2026-03-06).
Who are the largest shareholders of Trinity Biotech plc?
By the share each holder's latest filing reports, the largest holders of Trinity Biotech plc on this page are Mico Ivd Holdings, LLC (17%), Perceptive Advisors LLC (9.9%) and Novus Diagnostics LTD. (5.99%).
When did Mico Ivd Holdings, LLC buy into Trinity Biotech plc?
The filings give report dates, not purchase dates. The earliest filing from Mico Ivd Holdings, LLC on this page is the Schedule 13D/A, filed 2025-12-04, reporting 17%; its latest, Schedule 13D/A filed 2025-12-10, reports 17%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Trinity Biotech plc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Trinity Biotech plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Trinity Biotech plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Trinity Biotech plc raised?
Latest IPO step: Trinity Biotech plc amended its IPO registration (F-1/A, 2026-08-21).
IPO filings: F-1/A, 2026-08-21, RW, 2026-06-03, F-1/A, 2026-06-03, F-1, 2026-02-25, F-1, 2026-01-15.
Keep reading
More on Trinity Biotech plc and the records around it.
Trinity Biotech plc elsewhere on the record
- 5%+ stake filings May 2026
Companies that share a holder
- Perceptive Advisors LLC also filed stake reports on 57 other companies: Nautilus Biotechnology, Inc. (Nov 2026), Athira Pharma, Inc. (Oct 2026), IRulya Therapeutics Inc. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/trinity-biotech